Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study.
Lars Henrik JensenSilvia Regina RogattoJan LindebjergBirgitte HavelundCecilie AbildgaardLuisa Matos do CantoChris Vagn-HansenClaus DamSøren RafaelsenTorben Frøstrup HansenPublished in: Journal of experimental & clinical cancer research : CR (2023)
ClinicalTrials.gov, register NCT03251612.